AI CAPITAL INTELLIGENCE
智宠制药 · Series A1 · CNY 20,000,000–90,000,000 (reported range) · 2026-10-23
Financing facts, at a glance
智宠制药: financing disclosed on 2026-10-23, Series A1, CNY 20,000,000–90,000,000 (reported range). Named investors: 天汇资本. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment.
智宠制药 is recorded in the Industry AI / Drug discovery & life sciences segment. The disclosed financing is Series A1, with an amount of CNY 20,000,000–90,000,000 (reported range). Named investors include 天汇资本.
- Disclosed company name
- 智宠制药（苏州）有限公司
- Disclosure date
- 2026-10-23
- Round
- Series A1
- Financing amount
- CNY 20,000,000–90,000,000 (reported range)
- Market coverage
- China
- Sector
- Industry AI / Drug discovery & life sciences
- Product form
- Models & APIs
Disclosed investors
天汇资本
Sources for this round
- 智宠制药完成数千万元A1轮融资，重塑宠物药研发
news.pedaily.cn · Original publication date not recorded
- 智宠制药完成数千万元A1轮融资，重塑宠物药研发
sohu.com · Original publication date not recorded
Historical and background sources
- 智宠制药完成数千万元天使轮融资
investorscn.com · Original publication date not recorded
Collection batch . Reported ranges and lower bounds are retained. Financing proceeds are not company valuation.
Citation and coverage
Compiled and linked by Wavesight AI. Financing facts are attributable to the original disclosure sources; coverage is our recorded sample, not the whole market.
Wavesight AI｜智宠制药 · Series A1 · CNY 20,000,000–90,000,000 (reported range) · 2026-10-23。智宠制药: financing disclosed on 2026-10-23, Series A1, CNY 20,000,000–90,000,000 (reported range). Named investors: 天汇资本. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment. Compiled and linked by Wavesight AI. Financing facts are attributable to the original disclosure sources; coverage is our recorded sample, not the whole market. https://www.zkdlj.vip/en/funding/FI-ddbd444b3cd1a2a8/#conclusion-overview
Link to conclusion